Literature DB >> 9243032

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

J E Edwards1, G P Bodey, R A Bowden, T Büchner, B E de Pauw, S G Filler, M A Ghannoum, M Glauser, R Herbrecht, C A Kauffman, S Kohno, P Martino, F Meunier, T Mori, M A Pfaller, J H Rex, T R Rogers, R H Rubin, J Solomkin, C Viscoli, T J Walsh, M White.   

Abstract

Because of the rapidly increasing incidence of serious candidal infections, a consensus conference of 22 investigators from the United States, Europe, and Japan was held to discuss strategies for the prevention and treatment of deep-organ infections caused by Candida species. Commonly asked questions concerning the management of candidal infections were selected for discussion by the participating investigators. Possible answers to the questions were developed by the investigators, who then voted anonymously for their preferences. In certain instances, unanimity or a strong consensus was the result. In all cases, the full spectrum of responses was recorded and is presented in this report. The forms of candidal infection addressed included candidemia, candiduria, hepatosplenic candidiasis (chronic systemic candidiasis), candidal endophthalmitis, and candidal peritonitis. Prevention and treatment strategies were considered for patients who have undergone surgery, for neutropenic and nonneutropenic patients, and for patients who have undergone bone marrow and solid organ transplantation. The therapeutic roles of amphotericin B (standard and lipid formulations) and the azoles were considered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243032     DOI: 10.1086/514504

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  65 in total

1.  Management of Infections Caused by Candida glabrata.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Influence of liposomal amphotericin B on CD8 T-cell function.

Authors:  M Kretschmar; G Geginat; T Bertsch; S Walter; H Hof; T Nichterlein
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Candiduria: When and How to Treat It.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

4.  Genotyping of Candida albicans oral strains from healthy individuals by polymorphic microsatellite locus analysis.

Authors:  Frédéric Dalle; Laure Dumont; Norélie Franco; David Mesmacque; Denis Caillot; Pierre Bonnin; Caroline Moiroux; Odile Vagner; Bernadette Cuisenier; Sarab Lizard; Alain Bonnin
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 6.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 7.  Prevention and management of incontinence-associated dermatitis.

Authors:  Denise Nix; Vicki Haugen
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

8.  Candida spp. colonization significance in critically ill medical patients: a prospective study.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Hervé Aube; Jean Marc Doise; Jean Pierre Quenot; Ludwig Serge Aho; Pascal Chavanet; Bernard Blettery
Journal:  Intensive Care Med       Date:  2005-02-12       Impact factor: 17.440

Review 9.  Nosocomial infections in neurocritical care.

Authors:  Rafael Ortiz; Kiwon Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

10.  Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials.

Authors:  D L Horn; L Ostrosky-Zeichner; M I Morris; A J Ullmann; C Wu; D N Buell; L L Kovanda; O A Cornely
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-15       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.